News about Market

Novartis Builds Global Biomedical Research Centre in San Diego

Novartis launches construction of a 466,000-square-foot biomedical research centre in San Diego, set to open in 2029, strengthening global drug discovery and advancing neuroscience, oncology and next-generation therapies.

Market | 09/02/2026 | By News Bureau |  187

Innovent Collaborates with Lilly to Develop New Medicines in Oncology and Immunology

The agreement grants Lilly an exclusive licence to develop and commercialise the programmes worldwide outside Greater China, while Innovent retains rights in Greater China.

Market | 09/02/2026 | By News Bureau |  176

Breckenridge Pharmaceutical Partners with Medichem Solutions to Expand US Hospital Injectable Portfolio

Breckenridge Pharmaceutical enters a strategic collaboration with Medichem Solutions to supply injectable medicines for anaesthesia, critical care and emergency use, strengthening its presence in the US hospital segment.

Market | 07/02/2026 | By News Bureau |  203

Angitia Biopharmaceuticals Bags USD 130 Million in Series D Capital Raise

Angitia Biopharmaceuticals has raised USD 130 million in a Series D financing round co-led by Frazier Life Sciences and Venrock Healthcare Capital Partners. The funds will be used to advance the clinical development of lead programmes AGA2118, AGA2115, AGA111 and other pipeline assets.

Market | 06/02/2026 | By News Bureau |  334

Insilico Medicine Receives USD 5 Million from Menarini

Insilico received an additional $5 million milestone from Menarini following first-in-patient dosing in a Phase I trial of MEN2501, a generative AI-designed KIF18A inhibitor for chromosomally unstable solid tumours.

Market | 05/02/2026 | By News Bureau |  269

Mankind Pharma Sees Margin Expansion, Chronic Segment Gains in Q3FY26

Mankind Pharma announced its consolidated financial results for the third quarter and nine months ended December 31, 2025, reporting steady growth driven by improved performance in its domestic pharmaceutical business and consolidation of its BSV portfolio.

Market | 04/02/2026 | By Darshana |  222

WHO, WTO and WCO Update Global Customs Codes to Fast-Track Vaccine Shipments by 2028

New customs codes under HS 2028 aim to improve global tracking and faster clearance of vaccines and essential medical supplies during health emergencies.

Market | 04/02/2026 | By News Bureau |  252

SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech

SanegeneBio has licensed one of its RNAi programmes to Genentech in a global collaboration valued at up to USD 1.7 billion, including a USD 200 million upfront payment, milestone-based development and commercialisation payments, and tiered royalties. Genentech will oversee worldwide clinical development and commercialisation.

Market | 03/02/2026 | By News Bureau |  232

Agomab Unveils Plans for Initial Public Offering

Agomab has appointed JP Morgan, Morgan Stanley, Leerink Partners and Van Lanschot Kempen as joint book-running managers for the proposed Initial Public Offering (IPO), marking a key step in its plans to access the public markets.

Market | 03/02/2026 | By News Bureau |  252

Breakthru Medicine Raises USD 60 Million Series A to Advance Cancer Drugs

Founded by biotech veterans Steve Potts, Mark Mulvihill and Brian Barnett, Breakthru Medicine has raised USD 60 million in Series A funding to advance its stealth oncology pipeline, including molecular glues, small molecules and novel ADC payloads.

Market | 02/02/2026 | By News Bureau |  271